Literature DB >> 21328196

Treatment of pathological gambling with disulfiram: a report of 2 cases.

C A Müller, R Banas, A Heinz, J Hein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328196     DOI: 10.1055/s-0031-1271683

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  6 in total

1.  Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.

Authors:  Patricia Di Ciano; Daniel F Manvich; Abhiram Pushparaj; Andrew Gappasov; Ellen J Hess; David Weinshenker; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2017-10-30       Impact factor: 4.530

2.  Update on the Pharmacological Treatment of Pathological Gambling.

Authors:  Scott A Bullock; Marc N Potenza
Journal:  Curr Psychopharmacol       Date:  2013

Review 3.  Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.

Authors:  Shih-Ku Lin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

4.  Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.

Authors:  Kristof Segher; Liesbeth Huys; Tania Desmet; Evi Steen; Stefanie Chys; Walter Buylaert; Peter De Paepe
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

5.  Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder.

Authors:  Patricia Di Ciano; Bernard Le Foll
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

6.  A Preliminary Study of DBH (Encoding Dopamine Beta-Hydroxylase) Genetic Variation and Neural Correlates of Emotional and Motivational Processing in Individuals With and Without Pathological Gambling.

Authors:  Bao-Zhu Yang; Iris M Balodis; Cheryl M Lacadie; Jiansong Xu; Marc N Potenza
Journal:  J Behav Addict       Date:  2016-05-19       Impact factor: 6.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.